Previous 10 | Next 10 |
The following slide deck was published by Invitae Corporation in conjunction with their 2020 Q3 earnings call. For further details see: Invitae Corporation 2020 Q3 - Results - Earnings Call Presentation
What a year it's been for Invitae (NYSE: NVTA) . Its shares have skyrocketed well over 180% year to date thanks mainly to its big acquisition of leading genomics analysis company ArcherDX. Invitae announced its third-quarter results after the market closed on Thursday. Did the m...
Invitae Corporation (NVTA) Q3 2020 Earnings Conference Call November 05, 2020, 04:30 PM ET Company Participants Laura D'Angelo - Head of IR Sean George - CEO Shelly Guyer - CFO Lee Bendekgey - CPO Bob Nussbaum - CMO Katherine Stueland - CCO Jason Myers - President Conference Call Participants...
Invitae (NVTA): Q3 Non-GAAP EPS of -$0.62; GAAP EPS of -$0.78 misses by $0.10.Revenue of $68.73M (+21.6% Y/Y) beats by $9.37M.Accessioned ~170,000 samples in Q3 compared to 129,000 in Q3 2019.Billable volume was ~157,000.Shares +2.87%.Press Release For further details see: Invitae EPS m...
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020 -- Strong results driven by comprehensive menu, customer relationships and consistent execution -- -- Landmark data supporting universal genetic testing in cancer and ...
[[AAXN]], [[ACLS]], [[ADT]], [[AGO]], [[AIG]], [[AINV]], [[ALRM]], [[ALTR]], [[AMCR]], [[AMH]], [[AMN]], [[ANGI]], [[APPN]], [[ATGE]], [[ATRC]], [[AVLR]], [[AYX]], [[AZPN]], [[BFAM]], [[BGS]], [[BHF]], [[BIGC]], [[BILL]], [[BKNG]], [[BLDP]], [[BMRN]], [[BNFT]], [[CABO]], [[CARG]], [[CDAY]], [...
Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate Cancer, Suggests Role for Broader Screening Canada NewsWire SAN FRANCISCO, Oct. 28, 2020 — Three-quarters of patients with genetic changes had clinically relevant findings, includi...
Gainers: [[DSS]] +26.5%. [[PRVB]] +8.4%. [[GRTS]] +4.7%. [[LILA]] +3.4%. [[NVTA]] +3.1%.Losers: [[ATHM]] -6.9%. [[MRIN]] -5.2%. [[CRMD]] -3.8%. [[QLYS]] -3.3%. [[CBAY]] -2.3%. For further details see: DSS, PRVB, ATHM and QLYS among after-hours movers
Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020 PR Newswire SAN FRANCISCO, Oct. 23, 2020 SAN FRANCISCO , Oct. 23, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today a...
Invitae (NVTA) will collaborate with Pacific Biosciences of California (PACB) to develop whole genome sequencing-based assays for pediatric epilepsy.The first phase of the research partnership will a whole sequencing study of a large pediatric epilepsy cohort derived from the Behind the Seizu...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...